Imiquimod and Photodynamic Therapy Are Useful in the Treatment of Porokeratosis in Children with Bone Marrow Transplantation | Zendy

GraciaCazaña Tamara | Zendy; VeraÁlvarez Jesús | Zendy; GarcíaPatos Vicente | Zendy; Gilaberte Yolanda | Zendy

Premium

Imiquimod and Photodynamic Therapy Are Useful in the Treatment of Porokeratosis in Children with Bone Marrow Transplantation

Author(s) -

GraciaCazaña Tamara,

VeraÁlvarez Jesús,

GarcíaPatos Vicente,

Gilaberte Yolanda

Publication year - 2015

Publication title -

pediatric dermatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.542

H-Index - 73

eISSN - 1525-1470

pISSN - 0736-8046

DOI - 10.1111/pde.12654

Subject(s) - medicine , porokeratosis , imiquimod , dermatology , photodynamic therapy , immunosuppression , bone marrow transplantation , transplantation , surgery , immunology , chemistry , organic chemistry

Porokeratosis is an uncommon disorder that affects keratinization. Immunosuppression may favor the development of porokeratotic lesions. Patients who receive allogenic transplants represent a therapeutic challenge to dermatologists. We report two cases of porokeratosis in children with bone marrow transplant and their excellent response to imiquimod and photodynamic therapy.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research